PuraStat is intended for hemostasis of mild and moderate bleeding post ESD or EMR, as an adjunct, bridge, prophylactic or rescue therapy for intraprocedural venous bleeding or prophylactic therapy to …

PuraStat is a slightly viscous solution of synthetic peptides. When in contact with blood, the synthetic peptide selfassembles into a 3-dimensional matrix which rapidly coats the bleeding point leading to …

PuraStat ® is a novel self-assembling peptide (SAP) used as a haemostatic agent in endoscopy, with widespread application in surgical settings.

PuraStat can be used to reduce postoperative bleeding after endoscopic submucosal resection (ESD), to achieve hemostasis during endoscopic intervention and applicable for bleeding Forrest …

PuraStat combines advanced hemostatic technology with user-friendly application, making it an essential tool for medical professionals in managing gastrointestinal bleeding.

Purastat is a new haemostatic agent (treatment that stops bleeding) which is licensed to treat bleeding from blood vessels in the gut. It is a liquid containing four peptides (protein building-blocks).

Purastat is a biocompatible synthetic polypeptide gel that is commonly used to prevent delayed bleeding (DB) after endoscopic procedures such as endoscopic mucosal resection (EMR) or endoscopic …

PuraStat fits requirements for a hemostat in endoscopy and enables precise work in a narrow space. It is inert, transparent, deliverable through endoscopic applicator, non-cohesive and not clogging.

Ready to use in pre-filled syringe for immediate use. PuraStat ® is a synthetic haemostatic material, based on synthetic peptides, in the form of a prefilled syringe.

May 9, 2023 · Recently, several studies have evaluated its use in acute gastrointestinal bleeding (GIB). To appraise the published literature further, we conducted a systematic review & meta-analysis of …